4.7 Editorial Material

World Tuberculosis Day 2023 theme Yes! We Can End TB!

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Multidrug-resistant tuberculosis in children: Are the same therapy options available worldwide?

Danilo Buonsenso et al.

Summary: The spread of drug-resistant tuberculosis (TB) has led to the development of new drugs and the reappraisal of old drugs. Ensuring access to child-friendly medicines for drug-resistant TB is crucial for reducing the global burden of TB. This perspective highlights the need for child-friendly formulations of second-line drugs to improve adherence to treatment regimens and prevent the development of additional drug resistance.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Programmatic management of tuberculosis preventive therapy: Past, present, future

Alberto Matteelli et al.

Summary: Tuberculosis infection is a global public health priority, but the proportion of infected individuals receiving preventive treatment is minimal due to limited diagnostic tests, long and toxic treatment, and suboptimal prioritization in global policies. Lack of monitoring and evaluation systems contributes to the neglect of tuberculosis infection.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study

Joanitah Nalunjogi et al.

Summary: This study aims to compare the number of tuberculosis (TB) cases, drug-resistant TB cases, and TB deaths in 2020 vs 2019 in 11 countries. The results show a decrease in TB cases and drug-resistant TB cases in most countries, except for a few. The TB mortality rate increased in most countries in 2020 compared to 2019. It is important to conduct similar studies in different settings and collect global treatment outcome data for TB/COVID-19 co-infected patients to comprehensively evaluate the medium-term impact of COVID-19 on TB services.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Community engagement in tuberculosis research: the EU-Patient-cEntric clinicAl tRial pLatforms (EU-PEARL) experience

Francesca Saluzzo et al.

Summary: Early engagement of community representatives is crucial for improving the relevance and effectiveness of tuberculosis research. It can enhance recruitment, retention, and adherence to trial schedules, as well as support the implementation of new policies. Capacity building and training are identified as significant gaps in community engagement in the TB field.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Newborn bacille Calmette-Gu & eacute;rin vaccination induces robust infant interferon- ? -expressing natural killer cell responses to mycobacteria

Melissa Murphy et al.

Summary: This study investigated the effects of BCG vaccination on tuberculosis and its impact on myeloid and NK cell responses. The results showed that newborn BCG vaccination was associated with increased frequencies of BCG-reactive cells and IFN-γ-expressing NK cells, but not with myeloid cells. Furthermore, BCG vaccination was correlated with the secretion of certain cytokines.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Genomic and geospatial epidemiology of Mycobacterium tuberculosis in Oman: first national insight using whole genome sequencing

Amina Al-Jardan et al.

Summary: This study used whole genome sequencing to analyze the epidemiology and geospatial distribution of tuberculosis in Oman, identifying multiple genotype clusters and predominant lineages. The considerable genetic variation in TB strains in Oman may be attributed to the high percentage of non-national population and frequent travel to high TB burden countries.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Infectious Diseases

COVID-19, the escalation of diabetes mellitus and the repercussions on tuberculosis

Pei Min Thong et al.

Summary: The COVID-19 pandemic has disrupted global tuberculosis control efforts, leading to an accumulation of undiagnosed TB cases. The increase in COVID-19-induced diabetes mellitus exacerbates the situation, as diabetes is a known risk factor for TB and worsens outcomes. This poses a significant challenge for TB control in low- and middle-income countries with a high TB burden.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection

Saeid Najafi-Fard et al.

Summary: This study aims to compare the plasma immune profile of patients with tuberculosis (TB)-COVID-19 with COVID-19, TB, or healthy controls, and to evaluate the specific responses to SARS-CoV-2 and Mycobacterium tuberculosis (Mtb) antigens in vitro. The results showed that TB-COVID-19 coinfection patients have a distinct immune signature compared to COVID-19, and their immune response to SARS-CoV-2 and Mtb is significantly impaired.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Update of drug-resistant tuberculosis treatment guidelines: A turning point

Elisa Vanino et al.

Summary: In December 2022, the World Health Organization released new treatment guidelines for multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB). The update introduces two key recommendations: a 6-month treatment regimen consisting of multiple drugs and an all-oral 9-month regimen for patients with MDR/RR-TB. These guidelines represent a significant advancement in the treatment of MDR/RR-TB, but challenges remain for their full implementation.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Infectious Diseases

COVID-19, the escalation of diabetes mellitus and the repercussions on tuberculosis

Pei Min Thong et al.

Summary: The COVID-19 pandemic has disrupted global tuberculosis control efforts, leading to undiagnosed TB cases. Additionally, COVID-19-induced diabetes mellitus is increasing, which is a risk factor for TB disease and worsens outcomes. This poses a significant challenge to TB control, especially in low- and middle-income countries with high TB burden.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Newborn bacille Calmette-Guerin vaccination induces robust infant interferon-gamma-expressing natural killer cell responses to mycobacteria

Melissa Murphy et al.

Summary: This study investigated the effects of newborn BCG vaccination on myeloid and NK cell responses to mycobacteria. The results showed that newborn BCG vaccination was associated with higher frequencies of BCG-reactive, cytokine-expressing CD4(+) T cells and IFN-gamma-expressing NK cells compared to unvaccinated infants.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Editorial Material Medicine, General & Internal

Covid-19's Devastating Effect on Tuberculosis Care - A Path to Recovery

Madhukar Pai et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Public, Environmental & Occupational Health

Tuberculosis in times of COVID-19

Alexandra Jaye Zimmer et al.

Summary: The COVID-19 pandemic has severely disrupted tuberculosis care and service delivery, setting back progress in the fight against TB. By drawing on the comprehensive approaches used to manage COVID-19, the TB community can strengthen the global TB response through multisectoral collaborations.

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2022)

Article Infectious Diseases

The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection

Delia Goletti et al.

Summary: The article discusses the tests available for diagnosing tuberculosis (TB) infection, options for preventive therapy, and the importance of a TB infection registry in controlling the disease. The current tests lack accuracy in identifying individuals who will develop TB disease from those who will not. Shorter duration preventive therapies are available but need global implementation. The establishment of a TB infection registry is crucial for improving the cascade of care and achieving better TB control.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Review Respiratory System

A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations

James Mahon et al.

Summary: This review examines the cost-effectiveness of testing and treatment for latent tuberculosis infection (LTBI) in high-risk groups using interferon gamma release assays (IGRAs) or a tuberculin skin test (TST). The results suggest that IGRAs are likely to be cost-effective in high-income countries for high-risk populations, although there is uncertainty in parameter values used in the studies. Further evidence is needed on the cost-effectiveness of different strategies in low to middle income countries and countries with high TB burden.

BMC PULMONARY MEDICINE (2022)

Letter Infectious Diseases

Impact of the COVID-19 pandemic on the detection of TB in Shanghai, China

Z. Wu et al.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2020)

Article Infectious Diseases

Impact of the COVID-19 Pandemic on Tuberculosis Control: An Overview

Kefyalew Addis Alene et al.

TROPICAL MEDICINE AND INFECTIOUS DISEASE (2020)

Article Respiratory System

Towards tuberculosis elimination: an action framework for low-incidence countries

Knut Loennroth et al.

EUROPEAN RESPIRATORY JOURNAL (2015)